Search Results
Search for other papers by André Wendindondé Nana in
Google Scholar
PubMed
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Search for other papers by Yu-Tang Chin in
Google Scholar
PubMed
Search for other papers by Chi-Yu Lin in
Google Scholar
PubMed
Search for other papers by Yih Ho in
Google Scholar
PubMed
Search for other papers by James A Bennett in
Google Scholar
PubMed
Search for other papers by Ya-Jung Shih in
Google Scholar
PubMed
Search for other papers by Yi-Ru Chen in
Google Scholar
PubMed
Integrated Laboratory, Center of Translational Medicine, Core Facility, Taipei Medical University, Taipei, Taiwan
Search for other papers by Chun A Changou in
Google Scholar
PubMed
Search for other papers by Jens Z Pedersen in
Google Scholar
PubMed
Search for other papers by Sandra Incerpi in
Google Scholar
PubMed
Search for other papers by Leroy F Liu in
Google Scholar
PubMed
Search for other papers by Jacqueline Whang-Peng in
Google Scholar
PubMed
Search for other papers by Earl Fu in
Google Scholar
PubMed
Doctoral Degree Program in Marine Biotechnology, National Sun Yat-Sen University, Taipei, Taiwan
Search for other papers by Wen-Shan Li in
Google Scholar
PubMed
Search for other papers by Shaker A Mousa in
Google Scholar
PubMed
Taipei Cancer Center, Taipei Medical University, Taipei, Taiwan
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Albany, New York, USA
Traditional Herbal Medicine Research Center of Taipei Medical University Hospital, Taipei Medical University, Taipei, Taiwan
Search for other papers by Hung-Yun Lin in
Google Scholar
PubMed
Department of Medicine, Albany Medical College, Albany, New York, USA
Search for other papers by Paul J Davis in
Google Scholar
PubMed
of relapse, which often leads to patients’ death. Novel therapeutic approaches are needed for this disease. The molecular pathogenesis of colon cancer encompasses the activation of several oncogenic signaling pathways, including the Wnt/β-catenin
Search for other papers by Sayantani Sarkar in
Google Scholar
PubMed
Search for other papers by Chandan Mandal in
Google Scholar
PubMed
Search for other papers by Rajender Sangwan in
Google Scholar
PubMed
Search for other papers by Chitra Mandal in
Google Scholar
PubMed
Introduction Aberrant Wnt/β-catenin signaling is often observed in various cancers ( Polakis 2000 , Moon et al . 2002 , Lustig & Behrens 2003 ). β-catenin is a ubiquitously expressed protein with multiple functions. Initially, this protein was
Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Campus Monteprincipe, Madrid, Spain
Search for other papers by Juan A Ardura in
Google Scholar
PubMed
Search for other papers by Luis Álvarez-Carrión in
Google Scholar
PubMed
Search for other papers by Irene Gutiérrez-Rojas in
Google Scholar
PubMed
Search for other papers by Peter A Friedman in
Google Scholar
PubMed
Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Campus Monteprincipe, Madrid, Spain
Search for other papers by Arancha R Gortázar in
Google Scholar
PubMed
Departamento de Ciencias Médicas Básicas, Facultad de Medicina, Universidad San Pablo-CEU, CEU Universities, Campus Monteprincipe, Madrid, Spain
Search for other papers by Verónica Alonso in
Google Scholar
PubMed
regulating bone morphogenetic proteins or the Wnt/β-catenin signaling pathway ( Friedman et al. 2009 , Palmer et al. 2014 , Zhu et al. 2016 ). However, no previous reports describe the effects of MINDIN on bone or whether a crosstalk between MINDIN
Department of Pathology and Laboratory Medicine, Department of Urology, University of Rochester Medical Center, Rochester, New York 14642, USA
Search for other papers by Yi Li in
Google Scholar
PubMed
Department of Pathology and Laboratory Medicine, Department of Urology, University of Rochester Medical Center, Rochester, New York 14642, USA
Search for other papers by Yichun Zheng in
Google Scholar
PubMed
Search for other papers by Koji Izumi in
Google Scholar
PubMed
Search for other papers by Hitoshi Ishiguro in
Google Scholar
PubMed
Search for other papers by Bo Ye in
Google Scholar
PubMed
Search for other papers by Faqian Li in
Google Scholar
PubMed
Search for other papers by Hiroshi Miyamoto in
Google Scholar
PubMed
mechanism by which AR signaling modulates bladder cancer progression remains poorly understood. The canonical Wnt/β-catenin signaling pathway has been shown to play a pivotal role in normal cell growth and differentiation, embryonic development, and
Search for other papers by Julie Le Mestre in
Google Scholar
PubMed
Search for other papers by Michaël Thomas in
Google Scholar
PubMed
Search for other papers by Céline Duparc in
Google Scholar
PubMed
Search for other papers by Pierre Val in
Google Scholar
PubMed
Search for other papers by Clémence Bures in
Google Scholar
PubMed
Search for other papers by Jean-Jacques Tuech in
Google Scholar
PubMed
Centre for Biological Resources, Rouen University Hospital, Rouen, France
Search for other papers by Jean-Christophe Sabourin in
Google Scholar
PubMed
Search for other papers by Stéphanie Baert-Desurmont in
Google Scholar
PubMed
Centre for Biological Resources, Rouen University Hospital, Rouen, France
Department of Endocrinology, Diabetes and Metabolic Diseases, Rouen University Hospital, Rouen, France
Clinical Investigation Centre, INSERM, CIC1404, Rouen University Hospital, Rouen, France
Search for other papers by Hervé Lefebvre in
Google Scholar
PubMed
Search for other papers by Estelle Louiset in
Google Scholar
PubMed
as the major cause of the development of benign cortisol-producing lesions ( Beuschlein et al. 2014 , Hannah-Shmouni et al. 2016 , Espiard et al. 2018 , Kamilaris et al. 2020 ). In addition, insulin-like growth factor 2, TP53 and β-catenin
Search for other papers by F Cetani in
Google Scholar
PubMed
Search for other papers by E Pardi in
Google Scholar
PubMed
Search for other papers by C Banti in
Google Scholar
PubMed
Search for other papers by P Collecchi in
Google Scholar
PubMed
Search for other papers by P Viacava in
Google Scholar
PubMed
Search for other papers by S Borsari in
Google Scholar
PubMed
Search for other papers by G Fanelli in
Google Scholar
PubMed
Search for other papers by A G Naccarato in
Google Scholar
PubMed
Search for other papers by F Saponaro in
Google Scholar
PubMed
Search for other papers by P Berti in
Google Scholar
PubMed
Search for other papers by P Miccoli in
Google Scholar
PubMed
Search for other papers by A Pinchera in
Google Scholar
PubMed
Search for other papers by C Marcocci in
Google Scholar
PubMed
). HRPT2 encodes a protein of 531 amino acids called parafibromin. Parafibromin is a tumor suppressor protein and has recently been linked to Wnt/β catenin pathway ( Mosimann et al . 2006 ). Activation of the Wnt/β-catenin pathway is involved in a
Search for other papers by María Jesús Larriba in
Google Scholar
PubMed
Search for other papers by Noelia Valle in
Google Scholar
PubMed
Search for other papers by Héctor G Pálmer in
Google Scholar
PubMed
Search for other papers by Paloma Ordóñez-Morán in
Google Scholar
PubMed
Search for other papers by Silvia Álvarez-Díaz in
Google Scholar
PubMed
Search for other papers by Karl-Friedrich Becker in
Google Scholar
PubMed
Search for other papers by Carlos Gamallo in
Google Scholar
PubMed
Search for other papers by Antonio García de Herreros in
Google Scholar
PubMed
Search for other papers by José Manuel González-Sancho in
Google Scholar
PubMed
Search for other papers by Alberto Muñoz in
Google Scholar
PubMed
analogues with reduced calcemic properties are being used in pre-clinical studies and clinical trials against colon cancer and other neoplasias. Colon cancer is one of the most frequent neoplasias and a major health problem worldwide. Wnt/β-catenin
Search for other papers by Silvia Pizzi in
Google Scholar
PubMed
Search for other papers by Cinzia Azzoni in
Google Scholar
PubMed
Search for other papers by Elisa Tamburini in
Google Scholar
PubMed
Search for other papers by Lorena Bottarelli in
Google Scholar
PubMed
Search for other papers by Nicoletta Campanini in
Google Scholar
PubMed
Search for other papers by Tiziana D'Adda in
Google Scholar
PubMed
Search for other papers by Giovanni Fellegara in
Google Scholar
PubMed
Search for other papers by Tu Vinh Luong in
Google Scholar
PubMed
Search for other papers by Claudio Pasquali in
Google Scholar
PubMed
Search for other papers by Giulio Rossi in
Google Scholar
PubMed
Search for other papers by Gianfranco Delle Fave in
Google Scholar
PubMed
Search for other papers by Roberta Camisa in
Google Scholar
PubMed
Search for other papers by Cesare Bordi in
Google Scholar
PubMed
Search for other papers by Guido Rindi in
Google Scholar
PubMed
, located on chromosome 5q21-22, is mutated in the majority of colon cancers and acts as antagonist of the Wnt signalling pathway. The loss of APC function leads to the stabilization of β-catenin in the cytoplasm, followed by its migration in the nucleus
Search for other papers by Ming-Chuan Hsu in
Google Scholar
PubMed
Search for other papers by Hui-Chiu Chang in
Google Scholar
PubMed
Search for other papers by Wen-Chun Hung in
Google Scholar
PubMed
vector was provided by Dr Hung MC (MD Anderson Cancer Center, USA). Human β-catenin expression vector was obtained from Dr Wang CH (Kaohsiung Medical University, Taiwan). Dominant-negative ERK2 expression vector was obtained from Dr Lin WW (National
Search for other papers by David L Vesely in
Google Scholar
PubMed
within cancer cells are VEGF, the VEGFR2 receptor, β-catenin, secreted frizzled receptor, JNK, STAT3, and the WNT pathway. RTK, tyrosine kinase receptor; SRC, rous sarcoma viral proto-oncogene tyrosine kinase; SHC, rous sarcoma SH2 C-terminal binding